Market closed
CARGO Therapeutics, Inc./$CRGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CARGO Therapeutics, Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
Ticker
$CRGX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
167
Website
CRGX Metrics
BasicAdvanced
$214M
-
-$3.72
-
-
Price and volume
Market cap
$214M
52-week high
$4.72
52-week low
$3.58
Average daily volume
779K
Financial strength
Current ratio
13.786
Quick ratio
13.655
Long term debt to equity
7.994
Total debt to equity
8.169
Management effectiveness
Return on assets (TTM)
-27.01%
Return on equity (TTM)
-43.76%
Valuation
Price to book
0.59
Price to tangible book (TTM)
0.59
Price to free cash flow (TTM)
-1.438
Growth
Earnings per share change (TTM)
-77.46%
3-year earnings per share growth (CAGR)
-54.04%
CRGX News
AllArticlesVideos
CARGO Therapeutics Provides Corporate Update
GlobeNewsWire·1 month ago
Lost Money on CARGO Therapeutics, Inc.(CRGX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Accesswire·2 months ago
An Investigation Has Been Launched Into CARGO Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CARGO Therapeutics, Inc. stock?
CARGO Therapeutics, Inc. (CRGX) has a market cap of $214M as of April 19, 2025.
What is the P/E ratio for CARGO Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for CARGO Therapeutics, Inc. (CRGX) stock is 0 as of April 19, 2025.
Does CARGO Therapeutics, Inc. stock pay dividends?
No, CARGO Therapeutics, Inc. (CRGX) stock does not pay dividends to its shareholders as of April 19, 2025.
When is the next CARGO Therapeutics, Inc. dividend payment date?
CARGO Therapeutics, Inc. (CRGX) stock does not pay dividends to its shareholders.
What is the beta indicator for CARGO Therapeutics, Inc.?
CARGO Therapeutics, Inc. (CRGX) does not currently have a Beta indicator.